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AbstrACt
Introduction At the 72nd World Health Assembly of 
May 2019, WHO member states prioritised a global 
action plan to promote migrant and refugee health. 
Five months earlier, WHO had declared vaccine 
hesitancy—the reluctance to vaccinate despite the 
availability of vaccination services—as one of the top 
10 threats to global health. Although vaccination is often 
a requirement for immigration, repeated outbreaks of 
vaccine- preventable diseases within certain immigrant 
communities in some host nations suggest that vaccine 
hesitancy could be a factor in their susceptibility to 
vaccine- preventable diseases. Studies of the prevalence 
and determinants of vaccine hesitancy among migrants 
globally seem to be lacking. This scoping review will (1) 
identify articles on vaccine hesitancy among migrants; (2) 
examine the extent and nature of the extant evidence; and 
(3) determine the value of undertaking a full systematic 
review.
Methods and analysis The framework for the scoping 
review proposed by the Joanna Briggs Institute will be 
used. The reporting will follow the Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses 
extension for Scoping Reviews checklist. Studies published 
in English or French between January 1999 and December 
2019 will be drawn from most or all of the following 
multidisciplinary databases: Africa- Wide Information, 
Allied and Complementary Medicine, Cochrane Library, 
Cumulative Index of Nursing and Allied Health Literature, 
Embase, Index Medicus for the Eastern Mediterranean 
Region, International Bibliography of Social Sciences, 
Literature in the Health Sciences in Latin America and 
the Caribbean, Medline, Proquest Theses/Dissertations, 
PsycInfo and Web of Science. The search will include an 
extensive list of keywords to capture multiple dimensions 
of confidence and hesitancy vis-à-vis vaccines among 
migrants. Findings will be reported through summary 
narratives, tables, flowcharts and evidence maps.
Ethics and dissemination This review is exempted from 
ethical approval and will be published in a peer- reviewed 
open- access journal to ensure wide dissemination.
IntroduCtIon
Disparities in opportunity structures often 
compel people to move, internally or inter-
nationally. Therefore, migration is a universal 
phenomenon that affects most countries. 
Migrants are driven by many factors including 
the prospects of improving their access to 
work, civil, political and religious rights, secu-
rity and healthcare.1 One important aspect of 
healthcare that may affect migration is immu-
nisation. People are often required to vacci-
nate in order to immigrate.2–4 In contrast, 
access to vaccination and continuity of care 
are more challenging for people on the 
move such as migrants, refugees or nomadic 
populations.5 6 Long after they have settled 
in the host country, vaccination coverage 
among migrants may still be suboptimal when 
compared with that of the general popula-
tion.7 8 Vaccine sceptics and populist politi-
cians in some host countries openly challenge 
the scientific consensus about the effective-
ness and safety of vaccination.9–11 As a result, 
some migrants with pre- established concerns 
about vaccination may see their concerns 
reinforced, whereas others may succumb to 
anti- immunisation messaging and begin to 
question the benefits of some vaccines. The 
repeated measles outbreaks among Somali- 
Americans are instructive.12–14
Measles, a highly contagious respira-
tory disease and the leading cause of 
strengths and limitations of this study
 ► This review will synthesise evidence of vaccine hes-
itancy among migrants over two decades.
 ► This review will glean out evidence from all WHO 
regions.
 ► This review will include both qualitative and quanti-
tative studies published in English or French.
 ► The search, synthesis, and reporting of evidence will 
be guided by recommendations from the Joanna 
Briggs Institute and the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses exten-
sion for Scoping Reviews checklist.
 ► One possible limitation of this review is the poten-
tial exclusion of important studies not published in 
English or French.
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Table 1 PICO elements for study selection criteria
Participant/



































PICO, Participants, Intervention, Comparators and Outcome.
vaccine- preventable infant mortality worldwide, was 
declared eliminated in the USA in 2000.12 Since the 
elimination, however, several outbreaks have occurred in 
various US states with index cases often linked to overseas 
travels.13–15 In 2011 and 2017, two measles outbreaks with 
a total number of 100 cases, 72% of which were members 
of the Somali community of Hennepin County, Minne-
sota, occurred in the USA.16 17 Prior to the 2011 outbreak, 
measles- mumps- rubella (MMR) vaccine coverage among 
2- year- old Somali children in Minnesota had declined 
significantly from >91% in 2004 to 54% in 2010, as Somali 
parents began refusing MMR vaccine for their children 
owing to concerns of high autism rate in their commu-
nity.11 18 By 2014, MMR vaccine uptake was down to 42% 
among 2- year- old Somali Minnesotan children.17 Many 
of these vaccine concerns and fears were also fuelled by 
local antivaccine activists and the author of a currently 
discredited Lancet study, now retracted, which associated 
the MMR vaccine with the development of autism.19 20
Likewise, during a 2011 measles outbreak in Norway, 8 
of 10 cases (80%) identified were from the Somali commu-
nity of Oslo.21 Although there is evidence of low measles 
vaccine uptake among Somali migrants in the USA and 
Norway, we do not currently know how prevalent this issue 
is among Somalis living in other Western nations or non- 
Western host countries with a much larger Somali dias-
pora (eg, Ethiopia, Kenya and Yemen). It is also unclear 
whether, and if so why, Somali migrants might be more 
represented among non- vaccinators than other African 
migrants. Emerging evidence from England reveals that 
human papillomavirus (HPV) vaccine acceptance could 
be very low among UK- based immigrant parents from 
Eastern, Southern and Western Africa due to fears that 
their young daughters might become promiscuous and 
even infertile after HPV vaccination.22
When vaccination services are available yet underuti-
lised and barriers to access are reduced, then psychosocial 
processes more so than structural factors may better 
explain low vaccination uptake. One such factor that 
conspires against universal vaccination coverage and 
is gaining currency in the literature is ‘vaccine hesi-
tancy’.23 Broadly defined as the reluctance to vaccinate 
despite the availability of vaccination services, vaccine 
hesitancy entails a continuum of complex and context- 
specific attitudes and behaviours, ranging from total 
acceptance to complete refusal, and varying across 
time, place and vaccines. Underlying factors of hesi-
tancy are issues of confidence, complacency and conve-
nience.24 25 The authoritative working group on vaccine 
hesitancy appointed by the WHO’s Strategic Advisory 
Group of Experts on Immunization (SAGE) has devel-
oped a multilevel explanatory model of vaccine hesi-
tancy encompassing contextual influences (eg, religion, 
communication and media environment, politics and so 
on), individual/group factors (eg, beliefs, attitudes and 
motivation about health, trust in health system, past expe-
rience with vaccination, peer influence and so on), and 
vaccine- specific and vaccination- specific determinants 
(eg, cost, vaccination schedule, mode of administration 
and so on).24 Vaccine hesitancy theories and models may 
help to explain why some vaccine- hesitant individuals 
may accept all vaccines but remain concerned or unsure 
about vaccines, may shun or delay some vaccines yet 
accept others, or may refuse all vaccines.25–29
As a core topic, vaccine hesitancy is relatively new, with 
only six articles using the phrase in either the title or 
abstract between 2009 and 2011.29 Even its definition is 
still evolving while its qualification as a behaviour has been 
called into question.30 31 Yet, the resurgence and repeated 
outbreaks of vaccine- preventable diseases like measles that 
were considered eliminated in some Western countries 
have prompted WHO to declare vaccine hesitancy as one 
of the world’s top 10 threats to global health in 2019.32 If 
vaccine hesitancy is indeed a global threat to health and if 
migrant communities are potential ‘hotspots’ for vaccine 
hesitancy, then its prevalence and determinants within 
these communities must be examined. The overall aim of 
this scoping review is to take stock of the current evidence 
of vaccine hesitancy among migrants. Toward this end, 
the proposed review will address the following objectives:
1. Identify evidence of vaccine hesitancy among migrant 
individuals and communities.
2. Examine the extent and nature of the extant evidence.
3. Determine the value of undertaking a full systematic 
review.
Given the relative recency of vaccine hesitancy as a 
research area and given that we are not aware of any 
comprehensive evidence of vaccine hesitancy among 
migrant populations, the previously mentioned objec-
tives are suitable and consistent with the ‘reconnaissance’ 
purpose of the scoping review.33 Scoping will also allow 
us to identify and define crucial concepts, gaps in the 
literature, and types and sources of evidence to inform 
practice, policy and research.33 In choosing to focus on 
vaccine hesitancy, neither do we imply nor believe that 
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Table 2 Keywords and draft PMC search strategy for literature review on vaccine hesitancy















Acceptance, uptake, confidence, 
trust, anxiety, doubt, mistrust, 
anti- vaccination, anti- vax, 
concern, distrust, misinformation, 
resistance, compulsory, dropout, 
MMR, skeptic, critic, exemption, 
objector, attitude, choice, fear, 
opposition, autism, controversy, 
hesitancy, perception, rumor, 
rumour, avoidance, decision, 
hesitation, phobia, awareness, 
delay, intention, refusal, belief, 
barrier, denial, knowledge, 
rejection, dilemma, behavior, 
behavior, misconception, 
mandatory, reluctancy
((((((vaccination) OR vaccine) OR immunization) 
OR immunisation)) AND (((((((emigre) OR 
emigrant) OR immigrant) OR migrant) OR 
refugee) OR diaspora) OR foreigner)) AND 
((((((((((((((((((((((((((((((((((((((((((((((((((acceptance) OR 
anxiety) OR anti- vaccination) OR anti- vaxx) 
OR attitude) OR autism) OR avoidance) OR 
awareness) OR barrier) OR behavior) OR 
behaviour) OR concern) OR confidence) OR 
compulsory) OR controversy) OR choice) OR 
critic) OR delay) OR denial) OR decision) OR 
dilemma) OR distrust) OR doubt) OR dropout) 
OR exemption) OR fear) OR hesitancy) OR 
hesitation) OR intention) OR knowledge) 
OR mandatory) OR misconception) OR 
misinformation) OR mistrust) OR MMR) OR 
objector) OR opposition) OR perception) 
OR phobia) OR refusal) OR rejection) OR 
reluctance) OR resistance) OR rumor) OR 
rumour) OR skeptic) OR trust) OR uptake) AND 
(“1999/01/01”[PDat]: “2019/12/31”[PDat]))
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MMR, measles- mumps- rubella; PMC, PubMed Central.
the main determinant of underimmunisation in migrant 
populations is their reluctance to vaccinate. Political 
discourses that fuel prejudice and exclusion of the other, 
restrictive policies that deny good quality healthcare 
to the poor and access to universal health coverage to 
migrant populations, especially undocumented migrants, 
may represent far greater barriers to immunisation than 
vaccine hesitancy.34–36 However, we also believe that it is 
important to know the magnitude and nature of vaccine 
hesitancy in subpopulations like migrant communities 
because even very ‘small clusters of non- vaccinators can 
have disproportionately adverse effects on herd immunity 
and epidemic spread’.37
MEthods
A methodological framework for scoping review was first 
outlined by Arksey and O’Malley,38 subsequently clarified 
by Levac and colleagues,39 and further elaborated by the 
Joanna Briggs Institute (JBI).33 JBI’s elaboration of the 
framework contains 11 items: (1) title; (2) background; 
(3) review question/objective; (4) inclusion criteria; 
(5) types of participants; (6) concept; (7) context; (8) 
searching; (9) extracting and charting the results; (10) 
discussion; and (11) conclusions and implications for 
research and practice. We will apply this framework 
to organise our scoping review, supplementing it with 
recommendations from the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses extension for 
Scoping Reviews (PRISMA- ScR) checklist.40 This Methods 
section describes how we will address items 3–9 of the 
framework.
review question/objective
Instead of review questions, we have stated three main 
review objectives at the end of the introduction section: 
(1) identifying evidence of vaccine hesitancy among 
migrant individuals and communities; (2) examining 
the extent and nature of the existing evidence; (3) deter-
mining the value of undertaking a full systematic review.
Inclusion criteria
Articles will be included if they focus on the theme 
of vaccine hesitancy and its variations (eg, vaccine 
acceptance, vaccine confidence, vaccine attitudes and 
behaviours, trust, distrust, concerns, perceptions and 
beliefs about vaccines and vaccination programmes). Arti-
cles will be included if published in the last two decades 
(January 1999–December 2019) and if the full text is 
available in either French or English. Articles will be 
excluded if written in any language other than the above- 
mentioned languages and for which open- access auto-
mated translation programmes such as Google Translate 
are not suitable. Articles that do not focus on the human 
vaccine and that do not involve migrants will be excluded. 
Articles that focus on vaccine hesitancy in the wider popu-
lation but whose results are disaggregated by immigration 
status will be included. Given that this is a scoping review, 
all evidence will be included, from single- case reports to 
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Table 3 Data charting template
Data Data description
Study reference Name and surname of authors, 
publication year
Article type Quantitative, qualitative, mixed 
methods, research, review, policy, 
perspective, comment, letter, 
unpublished report, media article
Region of origin WHO region where country of study is 
located
Purpose Overall aim and objectives of the study
Population Main characteristics of populations, 
communities and individuals 
participating in the study
Country of 
immigration
Host country where migrant 
participants reside
Country of national 
origin
Foreign country where migrants 
or parents of second- generation 
immigrants came from
Country of transit Country where migrants may have 
resided as refugee before relocating in 
current host country




Neighbourhood, city or state where 
vaccination service is provided
Religion Main religion of migrants
Native language First language primarily spoken by 
migrants
Ethnic/racial identity Ethnic or racial group of migrants
Comparator Outgroup members with whom 
migrants are compared
Concept Underlying determinants of vaccine 
hesitancy explored by study
Intervention Types of intervention attempted 
or evaluated by study (eg, vaccine 
administration, health communication, 
policy, etc)
Outcome Outcomes from intervention (eg, 
increase, decrease or steady state in 
vaccination rate)
Vaccine Specific vaccine that is accepted, 
delayed or rejected
Findings Relevant key findings from study
population- level studies and from primary research to 
review articles, policy reports and commentaries.
types of participants
Target participants for this review are migrant popula-
tions, migrant communities and migrant individuals, 
including parents, expecting parents, childfree adults 
and children. We define migrants as including all individ-
uals whose country of national origin (or whose parents’ 
country of origin) is different from their country of 
residence, irrespective of the manner of entry and legal/
documented status in the host country. Further details on 
participants are provided in tables 1 and 2.
Concept
The concept or principal focus explored by this scoping 
review is vaccine hesitancy. As described in the previous 
section of this protocol, vaccine hesitancy is an inclu-
sive concept that encompasses varying degrees of inde-
cision about vaccination in general or certain vaccines 
in particular. Underlying factors of hesitancy include 
issues of confidence (do not trust vaccine or provider), 
complacency (do not perceive a need for a vaccine) and 
convenience (access).25 The final report from the SAGE 
Working Group on Vaccine Hesitancy states: ‘Vaccine- 
hesitant individuals may accept all vaccines but remain 
concerned about vaccines, some may refuse or delay some 
vaccines, but accept others; some individuals may refuse 
all vaccines’.24
Context
The context in this review could include the WHO 
regions of the studies, migrants’ host country, their home 
or origin country, their cultural heritage (eg, religion, 
language and health- seeking traditions), their residential 
neighbourhood and the location/place where vaccina-
tion services are provided.
searching
One of the most comprehensive systematic reviews of 
published literature on vaccine hesitancy to date was 
published in 2014 by members of the SAGE Working 
Group on Vaccine Hesitancy which includes one of the 
senior coauthors of this protocol.29 We will build on that 
2014 publication, identifying relevant studies for our 
scoping review through several of the same databases 
included in that systematic review. All or most of the 
following databases will be searched from 1 January 1999 
to 31 December 2019: Africa- Wide Information, Allied 
and Complementary Medicine, Cochrane Library, Cumu-
lative Index of Nursing and Allied Health Literature, 
Embase, Index Medicus for the Eastern Mediterranean 
Region, International Bibliography of Social Sciences, 
Literature in the Health Sciences in Latin America and 
the Caribbean, Medline, Proquest Theses/Dissertations, 
PsycInfo and Web of Science. Given that we aim at exam-
ining both the scientific and grey literature, we will also 
search Google and Google Scholar in addition to the 
multidisciplinary mainstream and regional databases 
listed earlier. Last, we will contact the authors of all studies 
included in our synthesis to identify potential additional 
sources. We anticipate that the search for articles will be 
run across all databases between May and June 2020.
To the extent possible, we will abide by the PRIS-
MA- ScR checklist to select relevant studies. Studies will be 
selected according to elements of the PICO (Participants, 
Intervention, Comparators and Outcome) model,40 as 
outlined in table 1. To capture multiple dimensions of 
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vaccine hesitancy among migrants, the search strategy will 
include the non- exhaustive list of keywords and medical 
subject headings in table 2. Once retrieved, all articles 
will first be screened by title and abstract by at least two 
reviewers to ascertain their relevance. When in doubt, 
the full article will be scanned to further determine its 
relevance or decide on its exclusion. Reference lists of 
relevant articles will also be perused to ensure literature 
saturation.
Extracting and charting the results
It is standard in scoping reviews to illustrate the numer-
ical outputs from the search and the inclusion decision 
process by means of a PRISMA flowchart. Our flowchart 
will clearly describe the review decision process, results 
from the search, removal of duplicate citations, study 
selection, full retrieval, any additions from reference list 
scanning and final summary presentation. In scoping 
review, ‘charting the results’ is an iterative process which 
involves the extraction of relevant data from all the 
studies included in the review.33 To enable consistency 
in data extraction among reviewers, we have developed a 
data charting template (table 3) to record characteristics 
of articles included and key data pertinent to the objec-
tives of our review. We anticipate refinement (or consol-
idation) of this form after data from a small sample of 
studies (two to three) have been charted independently 
by two or more reviewers. We anticipate that results of 
the review will include both quantitative and qualitative 
data. We will present these results through summary 
narratives and visuals such as evidence ‘maps’ and tabular 
presentations.
Protocol registration
This protocol is not registered in the International 
Prospective Register of Systematic Reviews (PROSPERO) 
because this registry does not accept scoping reviews.41
Patient and public involvement
This review will be based solely on published articles and 
will not involve any patients or the public.
EthICs And dIssEMInAtIon
This review will be based on published works, and thus 
is exempted from formal ethical approval. It will be 
published in a peer- reviewed open- access journal to 
ensure wide dissemination.
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